Friday afternoon Q & A (2017 Conference) (LDN, low dose naltrexone)

Questions on use of LDN in psoriasis, Lyme Disease, cancer, thyroid, diabetes, Crohn’s, MS, Lyme, vitiligo, other autoimmune diseases, administration route, dosing, nutrition, environmental toxins, LDN receptors, thymus proteins, peptides, stem cells, Vitamin D, insurance coverage for LDN, resources for testing and other treatments.

Saturday morning Q & A (2017 Conference) (LDN, low dose naltrexone)

Sunday Q & A (2017 Conference) (LDN, low dose naltrexone)

Saturday afternoon Q & A (2017 Conference) (LDN, low dose naltrexone)

Pharmacist-Prescriber Michael McCaughley - LDN Specialist (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

The LDN Research Trust's 8th LDN Specialist

Pharmacist Masoud Rashidi, PharmD - LDN Specialist (LDN, low-dose Naltrexone) from LDN Research Trust on Vimeo.

The LDN Side Effect Survey Results from 2020 - Jill Brook, MA (2021 Conference) (LDN, low dose naltrexone)

Jill Brook, MA is a Research Advisor to the LDN Research Trust. In this presentation she shares the results of the 2020 LDN Side Effect Survey.

The EMF Toxicity Epidemic - Protection and Treatment - Kent Holtorf, MD (2021 Conference) (LDN, low dose naltrexone)